Drug intelligence / Profile preview

piperacillin + tazobactam + dexamethasone

Development stage
Unknown
Lead developer
Pfizer
Modality
Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Administration
Intravenous, Intramuscular, Oral
01

Overview

Piperacillin + tazobactam + dexamethasone is a combination of two antibiotics and a corticosteroid. Piperacillin is an extended-spectrum penicillin antibiotic that exerts bactericidal activity by inhibiting bacterial cell wall synthesis. Tazobactam is a beta-lactamase inhibitor that prevents the enzymatic breakdown of piperacillin by beta-lactamase-producing bacteria, thereby extending its antibacterial spectrum[1][2][5][6]. Dexamethasone is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and immunosuppressant properties; it acts primarily through glucocorticoid receptor agonism to modulate gene expression and suppress inflammation. This combination may be used in clinical settings where both broad-spectrum antibacterial coverage and anti-inflammatory effects are desired, such as severe infections with significant inflammatory response or off-label in certain complex cases (e.g., severe pneumonia)[4]. The primary indications for piperacillin/tazobactam are moderate to severe bacterial infections including intra-abdominal, skin, gynecological, and respiratory tract infections[1][2][5].

Brand names
ZosynTazocin
02

Targets

GR (Glucocorticoid receptor)PBP (Penicillin-binding protein family)β-lactamase

Beyond the preview

Go deeper on piperacillin + tazobactam + dexamethasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on piperacillin + tazobactam + dexamethasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call